VRC 010 (05-I-0140)

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Booster Dose of a Recombinant Multiclade HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Subjects Who Where Previously Immunized with VRC-HIVDNA016-00-VP in VRC 00

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VRC) April 13, 2005
VRC-HIVADV014-00-VP Ad5 env A, env B, env C, gag B, pol B
VRC-HIVADV014-00-VP Viral Vector - Pox